Why We Need Artificial Intelligence to Predict the Probability of Success in Drug Development

This white paper explores the increasing challenges of drug development, where costs rise while productivity declines (Eroom’s Law), and how artificial intelligence (AI) offers a solution to reverse this trend.

In this white paper, you will learn:

• How AI and machine learning are revolutionizing drug development.
• The importance of accurate Probability of Technical and Regulatory Success (PTRS) assessments in making informed decisions about drug candidates.
• How AI can overcome the limitations of traditional PTRS approaches, providing objective, data-driven insights.
• The benefits of AI-driven PTRS assessments, including increased efficiency, reduced costs, and better resource allocation in drug development.